Sector
PharmaceuticalsOpen
₹1,299Prev. Close
₹1,298.05Turnover(Lac.)
₹6,943.79Day's High
₹1,425Day's Low
₹1,25552 Week's High
₹1,359.9552 Week's Low
₹432.05Book Value
₹228.35Face Value
₹10Mkt Cap (₹ Cr.)
6,984.02P/E
69.51EPS
18.68Divi. Yield
017 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
13 Jul 2023
12:00 AM
BookCloser
8 Jul 2023
12:00 AM
AGM
Announcement Date: 08 Jul, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 109.38 | 109.38 | 109.38 | 109.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 622.59 | 568.58 | 571.96 | 688.45 |
Net Worth | 731.97 | 677.96 | 681.34 | 797.83 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 556.97 | 450.69 | 505.44 | 644.16 |
yoy growth (%) | 23.58 | -10.83 | -21.53 | -14.71 |
Raw materials | -314.07 | -229.27 | -240.23 | -330.86 |
As % of sales | 56.38 | 50.87 | 47.52 | 51.36 |
Employee costs | -60.2 | -64.39 | -81.48 | -82.39 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -52.77 | -95.87 | -149.83 | -401.47 |
Depreciation | -87.02 | -108.89 | -125.9 | -133.29 |
Tax paid | 0 | 0 | 0 | 46.19 |
Working capital | -202.58 | -42.4 | 475.45 | -144.74 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.58 | -10.83 | -21.53 | -14.71 |
Op profit growth | -1.1 | -230.8 | -425.39 | -703.41 |
EBIT growth | -53.38 | -69.42 | 45.93 | -12.7 |
Net profit growth | -95.89 | -21.81 | -57.82 | -27.27 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 819.37 | 665.9 | 559.56 | 450.06 | 483.81 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 819.37 | 665.9 | 559.56 | 450.06 | 483.81 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 30.86 | 58.64 | 67.47 | 15.23 | 24.28 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Tanu Singla
Independent Director
Dharam Vir
Independent Director
Mudit Tandon
Independent Director
Manoj Goyal
Managing Director
Manish Dhanuka
Whole-time Director
Mridul Dhanuka
Chairman (Non-Executive)
Ram Gopal Agarwal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Orchid Pharma Ltd
Summary
Orchid Pharma Ltd., is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries. Orchids world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India. The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery, which was incorporated on 1st July 1992 as a 100% Export Oriented Unit (EOU). Orchid has two manufacturing sites for APIs (at Alathur near Chennai and at Aurangabad, near Mumbai) and three manufacturing sites for Dosage forms (at Irungattukottai and Alathur in Chennai), besides two R&D centres (at Sholinganallur and Irungattukottai, Chennai), all are state-of-the-art and have several international regulatory approvals, including the US FDA and UK MHRA. Orchids API facilities are ISO certified for their quality, environmental management and operational health and safety systems. Orchid has a Joint Venture in China for manufacturing sterile APIs. The Company commenced its operation in the year 1994, also in the same year
Read More
What is the Orchid Pharma Ltd share price today?
The Orchid Pharma Ltd shares price on N/A is Rs.₹1373.45 today.
What is the Market Cap of Orchid Pharma Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Orchid Pharma Ltd is ₹6966.02 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Orchid Pharma Ltd?
The PE and PB ratios of Orchid Pharma Ltd is 69.51 and 5.41 as of 22 Jul ‘24
What is the 52 Week High and Low of Orchid Pharma Ltd?
The 52-week high/low is the highest and lowest price at which a Orchid Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Orchid Pharma Ltd is ₹432.35 and ₹1358.8 as of 22 Jul ‘24
What is the CAGR of Orchid Pharma Ltd?
Orchid Pharma Ltd's CAGR for 5 Years at 192.07%, 3 Years at 34.65%, 1 Year at 110.33%, 6 Month at 71.60%, 3 Month at 21.74% and 1 Month at 11.79%.
What is the shareholding pattern of Orchid Pharma Ltd?
The shareholding pattern of Orchid Pharma Ltd is as follows:
Promoters - 69.84 %
Institutions - 19.69 %
Public - 10.47 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
